Our lawyers continue to get calls from eye injury victims looking to bring an Elmiron lawsuit in the last few weeks.  This class action is growing slowly but surely in 2022.

We do not know what the Elmiron settlement amounts will be. But I think these eye injury lawsuits have the potential to be extremely big cases with large individual settlement payouts. If you have a claim, you want to call an attorney sooner rather than later to protect your rights.

Our firm is currently accepting new Elmiron vision loss lawsuits. Call us today for a free case evaluation at 800-552-8082.

This blog provides an update on the hernia mesh lawsuits.  As of March 16, 2022, there are 16,437 lawsuits against Bard and 3,614 lawsuits against Ethicon (Johnson & Johnson) in federal court that are consolidated in an MDL class action lawsuit.

This page was last updated on April 15, 2022.

April 15, 2022 Update: Jury awarded $255,000 (which includes $5,000 to Mr. Milanesi’s wife for loss of consortium).  Plaintiff won on defective design claim.  Is this the big verdict our lawyers hoped for?  No.  But for bellwether effect, this verdict will do just fine.  And a win is a win.

Insurance companies do not think the way you and I think. But, by understanding how insurance adjusters think and what is important to them, you can maximize how much money you receive in a personal injury case.  The goal of this post is to show you how to get more money from the insurance adjuster.

What Is the Insurance Adjuster’s Goal?

Insurance adjusters are trained to rip you off.

This page is about the Similac recall lawsuit from the recall that was announced on February 2022.  Our lawyers are handling baby formula recall lawsuits NEC lawsuits in all 50 states.

There are more of these salmonella food poisoning claim out there from this recall than our attorneys had anticipated.  Our law firm has received hundreds of calls from victims’ parents.

If you have a potential claim, reach out to our lawyers today.

Over 600 Paraquat lawsuits have been filed around the U.S. by farmworkers and others who developed Parkinson’s disease from exposure to the herbicide Paraquat (grameoxone).

These lawsuits are based on a body of scientific evidence showing that prolonged exposure to Paraquat is linked to early-onset Parkinson’s disease in adults.

Our Paraquat lawyers are very enthusiastic about these lawsuits.  We believe the Paraquat lawsuits will likely succeed at trial. This will ultimately lead to high settlement amounts or jury payouts for victims.

Bellwether trials are basically “test” cases in large mass tort litigation involving thousands of plaintiffs. When you have thousands of individual plaintiffs bringing similar claims (usually product liability) it is not physically possible to take every case to trial.

Instead, a handful of sample cases are tried to give everyone involved in the litigation a clear idea of the settlement compensation payouts victims should receive.  These trials are bellwether trials.

In this post, we will explain the bellwether process in mass tort multidistrict litigation (MDL) cases. We will examine the role of bellwether trials and how individual cases are selected to serve as bellwether cases.

In Webb v. Giant of Maryland LLC, the Maryland Court of Appeals (COA) was asked to revisit the decision of the Court of Special Appeals (COSA).

The issue was whether the grocery store could be liable for an injury caused by a Pepsi delivery driver while stocking shelves at the store. The Pepsi delivery driver was an independent contractor and not a store employee of Giant. So the question was whether Giant still be liable for the Pepsi driver’s acts based on the level of control they had over him inside the store.

The  Maryland Court of Appeal affirmed the decision of COSA holding that Giant could not be held liable because the store did not exercise the necessary high level of control over the Pepsi driver.

While Bayer continues to settle large blocks of Roundup lawsuits, another Roundup jury trial is currently underway in California. Following a COVID delay, the trial in the case of plaintiff Donnetta Stephens has now converted to a virtual proceeding, making it one of the first “trials by zoom” in U.S. history.

This post, written on October 26, 2021, and updated on December 20, 2021, offers a snapshot of the latest Roundup lawsuit and its impact on settlement amounts in Phase Two (post-settlement) of the Roundup litigation.

[December 10, 2021 Update:  The 4th Roundup lawsuit to go trial resulted in a defense verdict for Bayer this week in the case of Donnetta Stephens v. Monsanto.  Stephens was a woman in her 70s who claimed that she used Roundup regularly in her garden for years and was subsequently diagnosed with lymphoma. The trial, as we discuss below, had to be held entirely by Zoom video conferencing (one of the first-ever “Zoom trials”) because of continuing COVID restrictions in California.

New scientific research has linked cow-milk-based infant formulas such as Similac and Enfamil to a dangerous neonatal medical condition known as necrotizing enterocolitis (NEC). A growing number of parents of infants who were fed with these I baby formulas and subsequently developed NEC are filing NEC formula lawsuits against the manufacturers (Abbott Laboratories and Mead Johnson Nutrition Co.). The lawsuits allege that Abbott and Meade had a duty to warn about the risks of NEC and their baby formula products, but deliberately failed to include any such warning while continuing to market their products as safe.

Example of a Recent NEC Infant Formula Lawsuit

The case of Grosshuhesch, et al. v. Mead Johnson Nutrition Company, et al., is one of the many Enfamil NEC infant formula lawsuits filed over the last half of 2021. The plaintiff, Abigail Grosshuhesch, brought the lawsuit on behalf of herself and on behalf of her deceased daughter, Isabella. Their Complaint was originally filed in Illinois State court against Mead Johnson Nutrition Company. On November 19, 2021, however, Mead Johnson removed the case to federal court (Southern District of Illinois).